Merck Raises 2026 Guidance After Q1 Revenue Beat, Despite $9B Deal Charge
Merck Q1 2026: $16.3B revenue beat, guidance raised. A $9B acquisition charge drove a GAAP loss, but Winrevair growth signals strong underlying fundamentals.
Merck Q1 2026: $16.3B revenue beat, guidance raised. A $9B acquisition charge drove a GAAP loss, but Winrevair growth signals strong underlying fundamentals.
Short selling lets investors profit from falling prices. Learn how it works, what short interest means, and what triggers a short squeeze.
The 30-year Treasury yield stands at 4.987% on April 30, 2026 — nearly 5% — as term premium surges on sticky inflation, rising supply, and fading foreign demand for US debt.
Eli Lilly beat Q1 2026 estimates with $19.8B revenue (+56%), EPS of $8.26 (+170%), driven by Mounjaro, Zepbound, and newly launched oral pill Foundayo.
Learn what the five options Greeks actually mean — delta, gamma, theta, vega, and rho — with worked examples, a data table, and charts that show how each measure changes in real market conditions.
Lincoln International filed an S-1 with the SEC to list on NYSE under ticker LCLN. With $783.8M in 2025 revenue and Goldman Sachs and Morgan Stanley as underwriters, here’s what it means for capital markets.
NXP Semiconductors surged 26% — its best day since listing in 2010 — as Q1 earnings beat estimates and Q2 guidance of up to $3.55B signaled a chip recovery led by auto and AI.
Learn how options work — what calls and puts are, how premiums are priced, and the difference between intrinsic and extrinsic value. Includes payoff diagrams.
Meta, Alphabet, Amazon and Microsoft will spend ~$700B on AI in 2026 — debt-funding is flooding the investment-grade bond market with record supply.
Meta, Alphabet, Amazon, and Microsoft posted Q1 2026 earnings beats this week—combined revenues hit $430 billion as AI investments begin delivering measurable results across the board.